These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 13406561)

  • 1. Studies of a plasma-cell neoplasm of the mouse. I. Characterization of neoplasm 70429, including its sensitivity to various antimetabolites with the rapid development of resistance to azaserine, DON, and N-methylformamide.
    POTTER M; LAW LW
    J Natl Cancer Inst; 1957 Mar; 18(3):413-41. PubMed ID: 13406561
    [No Abstract]   [Full Text] [Related]  

  • 2. Biologic studies on the development of DON resistance in a mast-cell neoplasm of the mouse.
    POTTER M
    J Natl Cancer Inst; 1959 Jul; 23(1):163-81. PubMed ID: 13673276
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of combinations of azaserine and of 6-diazo-5-oxo-L-norleucine with purine analogs and other antimetabolites on the growth of two mouse mammary carcinomas.
    TARNOWSKI GS; STOCK CC
    Cancer Res; 1957 Nov; 17(10):1033-9. PubMed ID: 13489704
    [No Abstract]   [Full Text] [Related]  

  • 4. The development and biochemical characterization of resistance to azaserine in a TA 3 ascites carcinoma.
    SARTORELLI AC; LePAGE GA
    Cancer Res; 1958 May; 18(4):457-63. PubMed ID: 13536997
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of uric acid biosynthesis in birds by o-diazoacetyl-L-serine (azaserine) and 6-diazo-5-oxo-L-norleucine (DON).
    KRAKOFF IH; KARNOFSKY DA
    Am J Physiol; 1958 Oct; 195(1):244-50. PubMed ID: 13583156
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects on DON (6-diazo-5-oxo-L-norleucine) and azaserine on the sand-dollar embryo.
    KARNOFSKY DA; BEVELANDER G
    Proc Soc Exp Biol Med; 1958 Jan; 97(1):32-7. PubMed ID: 13518172
    [No Abstract]   [Full Text] [Related]  

  • 7. Azaserine resistance in a plasma-cell neoplasm without change in active transport of the inhibitor.
    ANDERSON EP; JACQUEZ JA
    Cancer Res; 1962 Jan; 22():27-37. PubMed ID: 13861221
    [No Abstract]   [Full Text] [Related]  

  • 8. CROSS RESISTANCE AND COLLATERAL SENSITIVITY STUDIES IN CANCER CHEMOTHERAPY.
    HUTCHISON DJ
    Adv Cancer Res; 1963; 7():235-50. PubMed ID: 14153767
    [No Abstract]   [Full Text] [Related]  

  • 9. Resistance in L1210 ascites without change in concentrative uptake of o-diazoacetyl-L-serine or 6-diazo-5-oxo-L-norleucine.
    JACQUEZ JA; HUTCHISON DJ
    Cancer Res; 1959 May; 19(4):397-401. PubMed ID: 13652124
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of azaserine and 6-diazo-5-oxo-L-norleucine on the biosynthesis of inosinic acid de novo.
    BUCHANAN JM
    Tex Rep Biol Med; 1957; 15(1):148-53. PubMed ID: 13409287
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of ascites cell growth by combinations of 6-thioguanine and azaserine.
    SARTORELLI AC; LEPAGE GA
    Cancer Res; 1958 Sep; 18(8 Part 1):938-42. PubMed ID: 13573368
    [No Abstract]   [Full Text] [Related]  

  • 12. Biologic studies on the development of DON resistance in a mast-cell neoplasm of the mouse.
    POTTER M
    J Natl Cancer Inst; 1959 Jul; 23():163-81. PubMed ID: 14434476
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the effect of azaserine and azaserine with 6-mercaptopurine on the Yoshida sarcoma].
    YAMAGUCHI H; KURAHORI T; KUSUMOTO G; TERASHITA N; TABUCHI Y; ICHIHARA G; TOKITA Y; IKEDA E; FUKUI S
    Gan; 1956 Dec; 47(3-4):385-6. PubMed ID: 13415049
    [No Abstract]   [Full Text] [Related]  

  • 14. A short and efficient synthesis of L-5,5,5,5',5',5'-hexafluoroleucine from N-Cbz-L-serine.
    Anderson JT; Toogood PL; Marsh EN
    Org Lett; 2002 Nov; 4(24):4281-3. PubMed ID: 12443078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IV. Effect of O-diazoacetyl-L-serine (azaserine) on growth of various mouse and rat tumors.
    SUGIURA K; STOCK CC
    Proc Soc Exp Biol Med; 1955 Jan; 88(1):127-9. PubMed ID: 14357363
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diazo derivates of amino acids and peptides as possible antineoplastic chemotherapeutic agents. III. Activity on Galliera sarcoma of 2 N-diazoacetyl derivatives of glycine in comparison with azaserine and DON].
    BALDINI L; BRAMBILLA G; MATTIOLI F
    Boll Soc Ital Biol Sper; 1960 Nov; 36():1188-92. PubMed ID: 13686269
    [No Abstract]   [Full Text] [Related]  

  • 17. Active transport of O-diazoacetyl-L-serine and 6-diazo-5-oxo-L-norleucine in Ehrlich ascites carcinoma.
    JACQUEZ JA
    Cancer Res; 1957 Oct; 17(9):890-6. PubMed ID: 13472680
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of ascites tumor growth by 4-aminopyrazolo-(3,4-d)pyrimidine in combination with azaserine, 6-mercaptopurine, and thioguanine.
    HENDERSON JF; JUNGA IG
    Cancer Res; 1960 Dec; 20():1618-24. PubMed ID: 13713260
    [No Abstract]   [Full Text] [Related]  

  • 19. Variation in resistance patterns in different neoplasms.
    POTTER M
    Ann N Y Acad Sci; 1958 Dec; 76(3):630-42. PubMed ID: 13627890
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo sensitivity of normal and neoplastic mouse tissues to azaserine.
    MOORE EC; LEPAGE GA
    Cancer Res; 1957 Sep; 17(8):804-8. PubMed ID: 13460988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.